Fischer Medical Ventures Ltd.

Financial

	Fischer Medical	Epigral	Chemplast Sanmar
Operational Metrics
Financials
5 yr Average ROE	39.11 %	23.4 %	-14.92 %
5yr average Equity Multiplier	-0.03	2.24	0.34
5yr Average Asset Turnover Ratio	0.32	0.74	0.81
5yr Avg Net Profit Margin	-3.86 %	13.76 %	3.66 %
Price to Book	21.93	3.99	3.34
P/E	0.0	17.58	0.0
5yr Avg Cash Conversion Cycle	254.2 Days	22.15 Days	-160.25 Days
Inventory Days	25.95 Days	32.56 Days	44.16 Days
Days Receivable	200.41 Days	27.86 Days	14.51 Days
Days Payable	8.02 Days	48.15 Days	204.35 Days
5yr Average Interest Coverage Ratio	3.82	7.91	1.57
5yr Avg ROCE	20.39 %	23.79 %	15.83 %
5yr Avg Operating Profit Margin	5.78 %	29.74 %	12.16 %
5 yr average Debt to Equity	-1.28	0.81	-0.52
5yr CAGR Net Profit	n/a	28.82 %	n/a
5yr Average Return on Assets	-161.47 %	10.35 %	3.8 %
Shareholdings
Promoter Holding	61.8 %	68.83 %	54.99 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	61.8 %	-2.28 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	4.58 %	-0.11 %